Quote:
Originally Posted by Rmtt
You are fine. Give them a bit of time. I showed what the others were working on. DLPN is just a time game of waiting for them to release their earnings which is supposed to be anytime now. Torc will go too in time.
This is what Aiki is working on as they own the University of Maryland patents and are working with them. Don't know if I shared this with you guys.
|
Are you sure this is Aikido's product? They licensed antiviral compounds from UMD, not a vaccine platform as far as I can tell.
I am skeptical of antivirals being big sellers here because it's unlikely a novel compound can beat several of the vaccines to the market given the FDA approval process. Remdesivir already exists, too. So whatever they have has to be better and ideally in pill form or it'll be just like Remdesivir and not really an impact drug.